PMID: 42450048

Intravenous Everolimus Formulation (Sapu003) for Clinical Trials.

Min Sheng-Hao, Forero Kevin, Putnam William, Anderson Jonathan, Hoff Robert, Lopp John, Trieu Vuong, Ho Kwun, Lee Cynthia

International journal of molecular sciences · 2026

Vol. 27, Issue 13

View on PubMedDOI

This entry links to third-party literature. For research use only.

EverolimusHumansPolyethylene GlycolsAnimalsAntineoplastic AgentsNanoparticlesFemaleAdministration, IntravenousMiceDrug Compounding

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.